January 2009 melanotan-1 “afamelanotide” video from New Zealand

Please note that the statement, “A new drug developed in Australia” in the above video is only partially true. Melanotan-1 (NDP-MSH) was first synthesized by researchers at the University of Arizona. A paper of experiments first performed in Arizona with a controlled release formulation along the lines that Clinuvel has for the drug was first published by Bhardwaj R and Blanchard J in 1996: Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407.
A paper describing experiments using the exact same poly(D,L-lactide-co-glycolide) implant formulation of Clinuvel’s implant was published in 1998: In vitro characterization and in vivo release profile of a poly ( D, L -lactide-co-glycolide)-based implant delivery system for the α-MSH analog, melanotan-I
and another in 2000: Pharmacologic Response of a Controlled-Release PLGA Formulation for the Alpha-Melanocyte Stimulating Hormone Analog, Melanotan-I

more info: Melanotan.org – afamelanotide

January 2009 Australian video about melanotan-1 (“afamelanotide”) developments

More info: Melanotan.org – afamelanotide

Videos about melanotan-1 “afamelanotide”

A scientific description of melanotan-1 and how it works from one of its chief discoverers, endocrinologist Dr. Mac E. Hadley.

Excellent article about the melanotan peptides from Wired Magazine

Suntan Drug Greenlighted for Trials

More info:

Melanotan.org – afamelanotide – tanning drugs